| Added by | JPPOUGET |
|---|---|
| Group name | EquipeJPP |
| Item Type | Journal Article |
| Title | From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience |
| Creator | Pouget et al. |
| Author | Jean-Pierre Pouget |
| Author | Lore Santoro |
| Author | Bérengère Piron |
| Author | Salomé Paillas |
| Author | Riad Ladjohounlou |
| Author | Alexandre Pichard |
| Author | Sophie Poty |
| Author | Emmanuel Deshayes |
| Author | Julie Constanzo |
| Author | Manuel Bardiès |
| Abstract | Targeted radionuclide therapy (TRT) is used to treat disseminated or metastatic tumours in which conventional external beam radiotherapy (EBRT) would have unacceptable side effects. Unlike EBRT, TRT delivers low doses at a continuous low dose rate. In EBRT, the effect increases progressively with the dose rate, and biological effects (tumour control and normal tissue damage) are related to the dose according to a sigmoid curve model. This model is part of the so-called quantitative radiobiology that is mostly based on the target cell theory, according to which cell death is due to (lethal) radiation hits to vital cellular targets. This model was developed for EBRT, but was adapted to low dose-rate situations by including a parameter that reflects the time needed to repair tissue damage. However, a growing body of evidence indicates that the model should take into account also the biological effects, which are due to intercellular communications (bystander effects) and amplify the effects of radiation, as well as the immune system. Moreover, extranuclear targets must be considered, although induced intracellular and intercellular signalling pathways may ultimately result in DNA damage. It is likely that bystander effects and immune response always contribute to the overall response to TRT at different levels, and that dose and dose rate are key parameters in controlling their real contribution. We hypothesize that the dose rate is the key determinant in the balance between the physical and DNA-centred response on one side, and the biological response that integrates all subcellular compartments and intercellular signalling pathways on the other side. |
| Publication | Nuclear Medicine and Biology |
| Volume | 104-105 |
| Pages | 53-64 |
| Date | 2022 |
| Journal Abbr | Nucl Med Biol |
| Language | eng |
| DOI | 10.1016/j.nucmedbio.2021.11.005 |
| ISSN | 1872-9614 |
| Short Title | From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy |
| Library Catalog | PubMed |
| Extra | PMID: 34922279 |
| Tags | first-last-coresponding, Humans, Immune response, Neoplasms, Radiobiology, Radioisotopes, review, Signal Transduction, Target cell theory |
| Date Added | 2024/12/07 - 07:04:44 |
| Date Modified | 2024/12/15 - 10:30:49 |
| Notes and Attachments | PubMed entry (Attachment) PubMed entry (Attachment) PubMed entry (Attachment) |
Institut de Recherche en Cancérologie de
